𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Total HCV core antigen assay: A new marker of hepatitis C viremia for monitoring the progress of therapy

✍ Scribed by Alessandro R. Zanetti; Luisa Romanò; Maurizia Brunetto; Massimo Colombo; Giorgio Bellati; Charles Tackney


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
192 KB
Volume
70
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The ability of the total hepatitis C virus (HCV) core antigen assay was evaluated for monitoring the therapeutic responses of HCV‐infected patients treated with interferon. The ability to detect and quantitate an independent structural protein component of HCV, in the presence of circulating antibodies, makes this assay a valuable new tool in diagnosis and treatment monitoring. Measurement of total core antigen showed a strong dynamic correlation with HCV RNA data and may serve as an alternative direct marker of viral infection. In addition, with the advent of additional treatment protocols, a rapid, reliable assay for changes in HCV load may permit more frequent patient assessment and tailoring of the therapeutic regimen. J. Med. Virol. 70: 27–30, 2003. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Evaluation of a total hepatitis C virus
✍ Pierpaolo Valcavi; Maria Cristina Medici; Francesca Casula; Maria Cristina Arcan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

## Abstract A new, sensitive enzyme immunoassay has been developed for detecting and quantifying total hepatitis C virus (HCV) core antigen in anti‐HCV positive or negative sera (“__trak__‐__C__™”, Ortho Clinical Diagnostics, Raritan, NJ). The purpose of this study was to evaluate the performance o

Evaluation of a total core antigen assay
✍ N. Bouzgarrou; I. Fodha; S. Ben Othman; A. Achour; F. Grattard; A. Trabelsi; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Hemodialysis patients are recognized as a group at high risk of infection with hepatitis C virus (HCV). Therefore, such a population should be screened routinely for the presence of HCV viremia. Since nucleic acid techniques remain expensive and largely unavailable in many laboratories in the develo

Reliability of hepatitis C virus core an
✍ Salah Agha; Yasuhito Tanaka; Niveen Saudy; Fuat Kurbanov; Mostafa Abo-Zeid; Moha 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

## Abstract Nucleic acid amplification‐based methods are used for confirmation of viremia in antibody to hepatitis C virus (anti‐HCV)‐positive patients. However, this technology is labor intensive, time consuming, requires complex laboratory conditions, and expensive. The aim of this study was to e